> top > docs > PMC:1448208 > spans > 86-710 > annotations

PMC:1448208 / 86-710 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T728 3-8 UBERON:0001088 denotes urine
T729 38-43 NCBITaxon:4022 denotes Maple
T730 50-55 UBERON:0001088 denotes Urine
T731 93-103 GO:0008152 denotes metabolism
T732 145-154 CHEBI:25754 denotes keto acid
T733 420-426 NCBITaxon:33208 denotes animal
T734 455-461 NCBITaxon:39107 denotes murine
T735 493-497 SO:0000704 denotes gene
T736 512-521 UBERON:0000922 denotes embryonic
T737 512-531 CL:0002322 denotes embryonic stem cell
T738 557-562 NCBITaxon:10088 denotes mouse
T739 593-603 PR:000006300 denotes E2 subunit
T740 604-608 SO:0000704 denotes gene

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T775 3-8 UBERON:0001088 denotes urine
T776 38-43 NCBITaxon:4022 denotes Maple
T777 50-55 UBERON:0001088 denotes Urine
T778 93-103 GO:0008152 denotes metabolism
T779 145-154 CHEBI:25754 denotes keto acid
T780 234-240 CHEBI_GO_SO_EXT:enzyme denotes enzyme
T781 420-426 NCBITaxon:33208 denotes animal
T782 455-461 NCBITaxon:39107 denotes murine
T783 493-497 SO_EXT:0000704 denotes gene
T784 512-521 UBERON:0000922 denotes embryonic
T785 512-531 CL:0002322 denotes embryonic stem cell
T786 527-531 CL_GO_EXT:cell denotes cell
T787 557-562 NCBITaxon:10088 denotes mouse
T788 593-603 PR_EXT:000006300 denotes E2 subunit
T789 604-608 SO_EXT:0000704 denotes gene

craft-sa-dev

Id Subject Object Predicate Lexical cue
T843 9-16 NN denotes disease
T848 3-8 NN denotes urine
T849 16-17 sentence denotes
T850 27-37 sentence denotes Background
T851 27-37 NN denotes Background
T852 37-169 sentence denotes Maple Syrup Urine Disease (MSUD) is an inborn error of metabolism caused by a deficiency of branched-chain keto acid dehydrogenase.
T853 38-43 NN denotes Maple
T854 44-49 NN denotes Syrup
T855 56-63 NN denotes Disease
T856 50-55 NN denotes Urine
T857 71-73 VBZ denotes is
T858 64-65 -LRB- denotes (
T859 65-69 NN denotes MSUD
T860 69-70 -RRB- denotes )
T861 74-76 DT denotes an
T862 84-89 NN denotes error
T863 77-83 JJ denotes inborn
T864 90-92 IN denotes of
T865 93-103 NN denotes metabolism
T866 104-110 VBN denotes caused
T867 111-113 IN denotes by
T868 114-115 DT denotes a
T869 116-126 NN denotes deficiency
T870 127-129 IN denotes of
T871 130-138 VBN denotes branched
T872 139-144 NN denotes chain
T873 138-139 HYPH denotes -
T874 155-168 NN denotes dehydrogenase
T875 145-149 NN denotes keto
T876 150-154 NN denotes acid
T877 168-169 . denotes .
T878 169-252 sentence denotes MSUD has several clinical phenotypes depending on the degree of enzyme deficiency.
T879 170-174 NN denotes MSUD
T880 175-178 VBZ denotes has
T881 179-186 JJ denotes several
T882 196-206 NNS denotes phenotypes
T883 187-195 JJ denotes clinical
T884 207-216 VBG denotes depending
T885 217-219 IN denotes on
T886 220-223 DT denotes the
T887 224-230 NN denotes degree
T888 231-233 IN denotes of
T889 234-240 NN denotes enzyme
T890 241-251 NN denotes deficiency
T891 251-252 . denotes .
T892 252-343 sentence denotes Current treatments are not satisfactory and require new approaches to combat this disease.
T893 253-260 JJ denotes Current
T894 261-271 NNS denotes treatments
T895 272-275 VBP denotes are
T896 276-279 RB denotes not
T897 280-292 JJ denotes satisfactory
T898 293-296 CC denotes and
T899 297-304 VBP denotes require
T900 305-308 JJ denotes new
T901 309-319 NNS denotes approaches
T902 320-322 TO denotes to
T903 323-329 VB denotes combat
T904 330-334 DT denotes this
T905 335-342 NN denotes disease
T906 342-343 . denotes .
T907 343-433 sentence denotes A major hurdle in developing new treatments has been the lack of a suitable animal model.
T908 344-345 DT denotes A
T909 352-358 NN denotes hurdle
T910 346-351 JJ denotes major
T911 392-396 VBN denotes been
T912 359-361 IN denotes in
T913 362-372 VBG denotes developing
T914 373-376 JJ denotes new
T915 377-387 NNS denotes treatments
T916 388-391 VBZ denotes has
T917 397-400 DT denotes the
T918 401-405 NN denotes lack
T919 406-408 IN denotes of
T920 409-410 DT denotes a
T921 427-432 NN denotes model
T922 411-419 JJ denotes suitable
T923 420-426 NN denotes animal
T924 432-433 . denotes .
T925 433-442 sentence denotes Methods
T926 435-442 NNS denotes Methods
T928 443-445 TO denotes To
T929 446-452 VB denotes create
T930 488-492 VBD denotes used
T931 453-454 DT denotes a
T932 462-467 NN denotes model
T933 455-461 JJ denotes murine
T934 468-470 IN denotes of
T935 471-478 JJ denotes classic
T936 479-483 NN denotes MSUD
T937 483-485 , denotes ,
T938 485-487 PRP denotes we
T939 493-497 NN denotes gene
T940 498-507 NN denotes targeting
T941 508-511 CC denotes and
T942 512-521 JJ denotes embryonic
T943 527-531 NN denotes cell
T944 522-526 NN denotes stem
T945 532-544 NNS denotes technologies
T946 545-547 TO denotes to
T947 548-554 VB denotes create
T948 555-556 DT denotes a
T949 563-567 NN denotes line
T950 557-562 NN denotes mouse
T951 568-572 WDT denotes that
T952 573-579 VBD denotes lacked
T953 580-581 DT denotes a
T954 604-608 NN denotes gene
T955 582-592 JJ denotes functional
T956 593-595 NN denotes E2
T957 596-603 NN denotes subunit
T958 609-611 IN denotes of
T959 612-620 VBN denotes branched
T961 620-621 HYPH denotes -
R13 T853 T854 compound Maple,Syrup
R14 T854 T855 compound Syrup,Disease
R15 T855 T857 nsubj Disease,is
R17 T858 T855 punct (,Disease
R18 T859 T855 appos MSUD,Disease
R19 T860 T857 punct ),is
R20 T861 T862 det an,error
R21 T862 T857 attr error,is
R23 T864 T862 prep of,error
R24 T865 T864 pobj metabolism,of
R25 T866 T862 acl caused,error
R26 T867 T866 agent by,caused
R27 T868 T869 det a,deficiency
R28 T869 T867 pobj deficiency,by
R29 T870 T869 prep of,deficiency
R30 T871 T872 amod branched,chain
R31 T872 T874 compound chain,dehydrogenase
R33 T874 T870 pobj dehydrogenase,of
R36 T877 T857 punct .,is
R37 T879 T880 nsubj MSUD,has
R38 T881 T882 amod several,phenotypes
R39 T882 T880 dobj phenotypes,has
R41 T884 T880 prep depending,has
R42 T885 T884 prep on,depending
R43 T886 T887 det the,degree
R44 T887 T885 pobj degree,on
R45 T888 T887 prep of,degree
R46 T889 T890 compound enzyme,deficiency
R47 T890 T888 pobj deficiency,of
R48 T891 T880 punct .,has
R49 T893 T894 amod Current,treatments
R50 T894 T895 nsubj treatments,are
R51 T896 T895 neg not,are
R52 T897 T895 acomp satisfactory,are
R53 T898 T895 cc and,are
R54 T899 T895 conj require,are
R55 T900 T901 amod new,approaches
R56 T901 T899 dobj approaches,require
R57 T902 T903 aux to,combat
R58 T903 T899 advcl combat,require
R59 T904 T905 det this,disease
R60 T905 T903 dobj disease,combat
R61 T906 T895 punct .,are
R62 T908 T909 det A,hurdle
R63 T909 T911 nsubj hurdle,been
R65 T912 T909 prep in,hurdle
R66 T913 T912 pcomp developing,in
R67 T914 T915 amod new,treatments
R68 T915 T913 dobj treatments,developing
R69 T916 T911 aux has,been
R70 T917 T918 det the,lack
R71 T918 T911 attr lack,been
R72 T919 T918 prep of,lack
R73 T920 T921 det a,model
R74 T921 T919 pobj model,of
R77 T924 T911 punct .,been
R78 T928 T929 aux To,create
R79 T929 T930 advcl create,used
R80 T931 T932 det a,model
R81 T932 T929 dobj model,create
R83 T934 T932 prep of,model
R84 T935 T936 amod classic,MSUD
R85 T936 T934 pobj MSUD,of
R86 T937 T930 punct ", ",used
R87 T938 T930 nsubj we,used
R88 T939 T940 compound gene,targeting
R89 T940 T930 dobj targeting,used
R90 T941 T940 cc and,targeting
R91 T942 T943 amod embryonic,cell
R92 T943 T945 compound cell,technologies
R94 T945 T940 conj technologies,targeting
R95 T946 T947 aux to,create
R96 T947 T930 advcl create,used
R97 T948 T949 det a,line
R98 T949 T947 dobj line,create
R100 T951 T952 dep that,lacked
R101 T952 T949 relcl lacked,line
R102 T953 T954 det a,gene
R103 T954 T952 dobj gene,lacked
R107 T958 T954 prep of,gene
R12 T848 T843 compound urine,disease
R16 T856 T855 compound Urine,Disease
R22 T863 T862 amod inborn,error
R32 T873 T872 punct -,chain
R34 T875 T876 compound keto,acid
R35 T876 T874 compound acid,dehydrogenase
R40 T883 T882 amod clinical,phenotypes
R64 T910 T909 amod major,hurdle
R75 T922 T921 amod suitable,model
R76 T923 T921 compound animal,model
R82 T933 T932 amod murine,model
R93 T944 T943 compound stem,cell
R99 T950 T949 compound mouse,line
R104 T955 T954 amod functional,gene
R105 T956 T954 compound E2,gene
R106 T957 T954 compound subunit,gene